Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows(Unaudited)

v3.26.1
Condensed Consolidated Statements of Cash Flows(Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income $ 1,059,302 $ 865,933
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 931,771 1,102,085
Provision for bad debts 337,493 1,062,515
Gain on sale of assets (87,463) (28,320)
Stock based compensation 267,400 134,884
Changes in operating assets and liabilities:    
Accounts receivable (9,180,034) 6,408,397
Revenues in excess of billing (1,611,662) (1,411,983)
Other current assets 936,453 (344,493)
Accounts payable and accrued expenses 123,872 (1,136,533)
Unearned revenue 6,437,518 (6,646,170)
Net cash provided by (used in) operating activities (785,350) 6,315
Cash flows from investing activities:    
Purchases of property and equipment (1,379,262) (897,743)
Sales of property and equipment 85,851 63,577
Investment in associates 25,396
Purchase of subsidiary shares (8,878)
Increase in intangible assets (1,039,989)
Net cash used in investing activities (2,308,004) (843,044)
Cash flows from financing activities:    
Proceeds from the exercise of stock options and warrants 473,000
Proceeds from exercise of subsidiary options 387,200
Dividend paid by subsidiary to non-controlling interest (306,799)
Purchase of subsidiary treasury stock (1,503,662)
Proceeds from bank loans 1,076,226 2,451,256
Payments on finance lease obligations and loans - net (1,093,671) (247,496)
Net cash provided by financing activities 369,755 866,299
Effect of exchange rate changes 110,047 (381,996)
Net increase (decrease) in cash and cash equivalents (2,613,552) (352,426)
Cash and cash equivalents at beginning of the period 17,357,944 19,127,165
Cash and cash equivalents at end of period 14,744,392 18,774,739
Cash paid during the period for:    
Interest 617,486 619,451
Taxes $ 992,446 $ 1,185,546